A Look Back on 2025: Trends and Highlights From the National Infusion Collaborative

This webinar session focused on insights drawn from the NIC’s national infusion pump data and on questions submitted in advance by pharmacy, nursing, and medication safety leaders.

Rather than presenting abstract trends, the discussion centered on specific, operational challenges hospitals are navigating today: how to build oxytocin in the context of interoperability, how to structure biosimilars in the drug library, what rising bivalirudin alerting may signal, and what hospitals are learning through pump interoperability implementation.

The Top Questions Submitted By The Audience:

• For hospitals with labor & delivery units and interoperability, how have you built out the library entry for oxytocin to accommodate different dosing units and indications?

• With biosimilars, is the trend to build each product with a unique suffix, or use one primary entry?

• Have you seen an increase in alerts with bivalirudin?

• What impact does interoperability have on optimizing workflows and improving patient safety?

• Is there a number one thing hospitals wish they had known at initial implementation for pump interoperability?

• What are some challenges post-interoperability implementation?